Log in
OTCMKTS:ADTM

Adaptive Medias Stock Forecast, Price & News

$0.0001
0.00 (0.00 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.00
Volume18.36 million shs
Average Volume7.81 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.41
Adaptive Medias, Inc., a programmatic audience and content monetization company, provides digital video and mobile solutions for Website owners, app developers, and video publishers for optimize content through advertising. The company provides programmatic and real time bidding advertising solutions across mobile, video, and display, as well as a business-to-business digital video content management platform SaaS. Its platform provides a video player for publishers to offer supplement video libraries. The company provides a foundation for publishers and developers to engage brand advertisers through a multi-channel approach that delivers ads in various devices. The company was formerly known as Mimvi, Inc. and changed its name to Adaptive Medias, Inc. in November 2013. Adaptive Medias, Inc. was founded in 2007 and is headquartered in Irvine, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars

Industry, Sector and Symbol

Industry Advertising
Sub-IndustryN/A
Current SymbolOTCMKTS:ADTM
CUSIPN/A
Phone949-525-4634
Employees14

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
$0.0001
0.00 (0.00 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ADTM News and Ratings via Email

Sign-up to receive the latest news and ratings for ADTM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Adaptive Medias (OTCMKTS:ADTM) Frequently Asked Questions

How has Adaptive Medias' stock price been impacted by Coronavirus (COVID-19)?

Adaptive Medias' stock was trading at $0.0001 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ADTM shares have increased by 0.0% and is now trading at $0.0001.
View which stocks have been most impacted by COVID-19
.

Who are some of Adaptive Medias' key competitors?

What other stocks do shareholders of Adaptive Medias own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adaptive Medias investors own include Co-Diagnostics (CODX), Ibio (IBIO), Moleculin Biotech (MBRX), Kopin (KOPN), Opko Health (OPK), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP) and Vaxart (VXRT).

Who are Adaptive Medias' key executives?

Adaptive Medias' management team includes the following people:
  • Mr. John B. Strong, Chairman, CEO & Pres (Age 59)
  • Mr. Sulaiman Aziz, Co-Founder, GM of Platform & Director (Age 39)
  • Mr. Angel Mondragon, Pres of Cryptocurrency Transition
  • Mr. Mike Muldoon, Consultant

What is Adaptive Medias' stock symbol?

Adaptive Medias trades on the OTCMKTS under the ticker symbol "ADTM."

How do I buy shares of Adaptive Medias?

Shares of ADTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Adaptive Medias' stock price today?

One share of ADTM stock can currently be purchased for approximately $0.00.

What is Adaptive Medias' official website?

The official website for Adaptive Medias is www.adaptivem.com.

How can I contact Adaptive Medias?

Adaptive Medias' mailing address is 47 Discovery Suite 220, Irvine CA, 92618. The business services provider can be reached via phone at 949-525-4634 or via email at [email protected]

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.